Search - tctmd.com

Displaying 981 - 1000 of 1033

Sort: Relevancy | Date

News Industry News

Patients with ACS and/or diabetes who show poor response to dual antiplatelet therapy

November 08, 2011

News Industry News

Non-adherence to dual antiplatelet therapy following percutaneous coronary intervention results in higher rates of ischemic and bleeding events

November 08, 2011

News Conference News

Mock Jury Votes on DAPT Duration: 12 Months Remains Best Option for Most Patients

November 08, 2011

News Conference News

Low Event Rates with EES Sustained at 2 Years

November 08, 2011

News Conference News

Bioabsorbable Polymers, Scaffolds Offer Permanent Advantages

November 08, 2011

News Industry News

Three-Year Clinical Outcomes from Use of GenousTM Stent in Large, Real-World Patient Population Demonstrate Long-Term Safety and Efficacy

November 07, 2011

News Conference News

SAT-TAVI: Data Support TAVR Without Dual Antiplatelet Therapy

November 07, 2011

News Conference News

GHOST: Accurate Medical History May Predict DAPT Adherence in PCI for STEMI

November 06, 2011

News Conference News

Early Discontinuation of DAPT May Increase Risk of Stent Thrombosis

November 06, 2011

News Industry News

Data Published in Circulation Journal Show OrbusNeich's GenousTM Stent Is Safe and Effective in Elderly Patients

October 25, 2011

News Conference News

ESC Congress 2011: Drugs, Devices Work Together

Caitlin E. Cox

September 06, 2011

News Conference News

Long-term Antiplatelet Therapy: All Risk, No Benefit

August 30, 2011

News Industry News

OrbusNeich's GenousTM Stent Enables Early and Safe Discontinuation of Dual Antiplatelet Therapy in High-Risk Patients Requiring Nondeferrable, Non-Cardiac Surgery

July 18, 2011

News Conference News

EXCELLENT Outcomes Regardless of Antiplatelet Therapy Duration After DES

Caitlin E. Cox

April 05, 2011

News Daily News

Stent Thrombosis, Major Bleeding Rare with Sirolimus-Eluting Stents

March 21, 2011

Video

» Interview

Beyond the Data: Short-term Anticoagulation vs DAPT Post-LAAO

November 3, 2025

Video

» On Record

On Record: Putting Post-PCI DAPT Into Perspective

June 11, 2025

Video

» Interview

Beyond the Data: Best DAPT for DCBs

May 16, 2024

Video

» Topical Discussion

Stopping Amputation Post-revascularization: Novel Data in Mitigation of Thrombosis Risk

June 27, 2022

Video

» Interview

Beyond the Data: Abbreviated DAPT After Complex PCI in High-Bleeding-Risk Patients

May 18, 2022

Advertisement

Patients with ACS and/or diabetes who show poor response to dual antiplatelet therapy

Non-adherence to dual antiplatelet therapy following percutaneous coronary intervention results in higher rates of ischemic and bleeding events

Mock Jury Votes on DAPT Duration: 12 Months Remains Best Option for Most Patients

Low Event Rates with EES Sustained at 2 Years

Bioabsorbable Polymers, Scaffolds Offer Permanent Advantages

Three-Year Clinical Outcomes from Use of GenousTM Stent in Large, Real-World Patient Population Demonstrate Long-Term Safety and Efficacy

SAT-TAVI: Data Support TAVR Without Dual Antiplatelet Therapy

GHOST: Accurate Medical History May Predict DAPT Adherence in PCI for STEMI

Early Discontinuation of DAPT May Increase Risk of Stent Thrombosis

Data Published in Circulation Journal Show OrbusNeich's GenousTM Stent Is Safe and Effective in Elderly Patients

ESC Congress 2011: Drugs, Devices Work Together

Long-term Antiplatelet Therapy: All Risk, No Benefit

OrbusNeich's GenousTM Stent Enables Early and Safe Discontinuation of Dual Antiplatelet Therapy in High-Risk Patients Requiring Nondeferrable, Non-Cardiac Surgery

EXCELLENT Outcomes Regardless of Antiplatelet Therapy Duration After DES

Stent Thrombosis, Major Bleeding Rare with Sirolimus-Eluting Stents

Beyond the Data: Short-term Anticoagulation vs DAPT Post-LAAO

On Record: Putting Post-PCI DAPT Into Perspective

Beyond the Data: Best DAPT for DCBs

Stopping Amputation Post-revascularization: Novel Data in Mitigation of Thrombosis Risk

Beyond the Data: Abbreviated DAPT After Complex PCI in High-Bleeding-Risk Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content